Data / Form D filings / Medsyn Biopharma LLC
Medsyn Biopharma LLC: Form D filings
Medsyn Biopharma LLC, a pharmaceuticals company in Northville, MI, filed 3 Form D notices with the SEC between 2023 and 2025. The latest, on November 4, 2025, reports $11.5 million sold of a $11.5 million offering to 16 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 120 W Main St., Ste 300, Northville, MI, 48167
- Phone
- (610) 725-1500
- Industry
- Pharmaceuticals
- Entity type
- Limited Liability Company
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1966428
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 4, 2025 | New notice | $11,500,000 | $11,499,999 | $1 | 16 | Oct 20, 2025 | sec.gov |
| Aug 15, 2024 | New notice | $5,000,000 | $5,000,000 | 5 | Jul 31, 2024 | sec.gov | |
| Mar 3, 2023 | New notice | $3,090,000 | $3,090,000 | 6 | Feb 9, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Martin Mel Matthew | Executive Officer | |
| Brian Mel Wood | Executive Officer | |
| John Mel Sorensen | Executive Officer, Director | |
| Shaomeng Mel Wang | Director |
Other pharmaceuticals companies in Michigan that filed recently
- IMACS Working Capital Facility One LLC $200,000 · Sep 17, 2026
Every Form D from the week of Nov 3, 2025 · All recent filings in Michigan · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Medsyn Biopharma LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.